Polyclonal Antibodies Against Cardiovirus 2A, 2B, 2C, 3C, 3A, 3B and 3AB Proteins
Wisconsin Alumni Research Foundation (University of Wisconsin)
posted on 06/23/2009
The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in polyclonal antibodies against several cardiovirus proteins.
Suggested Uses
- Studying cardiovirus proteins
- May lead to new means of detecting, preventing and treating cardiovirus infection, including encephalomyocarditis virus infection
Advantages
- All reagents have been tested for efficacy.
- Most of the antibodies react with viral precursor proteins, in addition to the mature proteins against which they were raised.
Detailed Description
UW-Madison researchers have developed polyclonal mouse antibodies against recombinant cardiovirus proteins. The antibodies can be used for specific molecular recognition of the cardiovirus proteins in vitro or in vivo using experimental techniques such as ELISA (enzyme linked immunosorbent assay), Western assays, protein immunoprecipitation (IP) and confocal fluorescence microscopy.
File Number: P07499US
Other Information:
Aminev A.G., Amineva S.P. & Palmenberg A.C. 2003. Encephalomyocarditis Virus (EMCV) Proteins 2A and 3BCD Localize to Nuclei and Inhibit Cellular mRNA Transcription but not rRNA Transcription. Virus Res. 95, 59-73.
Aminev A.G., Amineva S.P. & Palmenberg A.C. 2003. Encephalomyocarditis Viral Protein 2A Localizes to Nucleoli and Inhibits Cap-Dependent mRNA Translation. Virus Res. 95, 45-57.
This innovation currently is not available for online licensing. Please contact Emily Bauer at Wisconsin Alumni Research Foundation (University of Wisconsin) for more information.
Find more innovations
